Holen Sie sich die Stockscreener-App
142.78
2.17%
-3.17
Handel nachbörslich:
142.78
Schlusskurs vom Vortag:
$145.95
Offen:
$145.41
24-Stunden-Volumen:
630.29K
Relative Volume:
1.35
Marktkapitalisierung:
$4.74B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-29.38
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
-5.74%
1M Leistung:
+1.51%
6M Leistung:
+59.64%
1J Leistung:
+44.79%
1-Tages-Spanne:
$141.79
$146.88
1-Wochen-Bereich:
$141.79
$157.13
52-Wochen-Spanne:
$55.92
$157.13
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
142.78 | 4.74B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
SHAREHOLDER ALERT: Morris Kandinov Investigating IRTC, - GlobeNewswire
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the - Bluefield Daily Telegraph
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss - GlobeNewswire
iRhythm at 2025 Truist Securities MedTech Conference: Strategic Growth Plans - Investing.com
Discretionary Denials in Action: iRhythm Technologies Inc. v. Welch Allyn Inc. | ProskauerThe Patent Playbook - JD Supra
File Early or Risk Denial: iRhythm IPR Institution Denial Underscores the Importance of Filing IPR Petitions Sooner Rather Than Later | Regulatory Roundup | Insights - Vinson & Elkins LLP
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Cardiovascular Digital Solutions Market Generated - openPR.com
GAMMA Investing LLC Acquires 8,660 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
iRhythm Creates a New Basis for Discretionary Denial - IPWatchdog.com
(IRTC) Investment Report - news.stocktradersdaily.com
Rhumbline Advisers Has $4.81 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
iRhythm Technologies (NASDAQ:IRTC) shareholders have earned a 57% return over the last year - Yahoo Finance
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
iRhythm: Promising OutlookSo Long As Past Mistakes Are Not Repeated (NASDAQ:IRTC) - Seeking Alpha
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
iRhythm Technologies (NASDAQ:IRTC) Given New $160.00 Price Target at Morgan Stanley - Defense World
iRhythm Technologies (NASDAQ:IRTC) versus Pulmonx (NASDAQ:LUNG) Head to Head Survey - Defense World
iRhythm Technologies (IRTC) Price Target Raised by Morgan Stanle - GuruFocus
Insider Sell: Chad Patterson Sells Shares of iRhythm Technologies Inc - GuruFocus
IRTC to be Featured in Upcoming BTIG Event in New York | IRTC St - GuruFocus
iRhythm Technologies (IRTC) Price Target Raised by Morgan Stanley | IRTC Stock News - GuruFocus
iRhythm at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Stewart's Newest Discretionary Denial Has Attys On Edge - Law360
iRhythm at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
iRhythm (IRTC) Gains Momentum as Morgan Stanley Raises Price Tar - GuruFocus
iRhythm (IRTC) Gains Momentum as Morgan Stanley Raises Price Target | IRTC Stock News - GuruFocus
Morgan Stanley Raises iRhythm Technologies Price Target to $160 From $130, Maintains Overweight Rating - MarketScreener
Cardiac Patch Monitor Market Outlook, Developments, and Strategic Insights by 2031 - openPR.com
Patent Chief Nixes iRhythm Challenges Citing Decade-Old Tech (1) - Bloomberg Law News
Stewart Grants Request to Deny IPR Institution Due to Patent Owner’s ‘Settled Expectations’ - IPWatchdog.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect - ACCESS Newswire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Patent Office Leader Rejects IPRs Based On 12-Year Wait - Law360
iRhythm Technologies stock hits 52-week high at $147 By Investing.com - Investing.com South Africa
iRhythm Technologies stock hits 52-week high at $147 - Investing.com
Should You Hold iRhythm Technologies (IRTC)? - Insider Monkey
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
U.S. Smart Wearable ECG Monitors Market Size Report 2030 - Grand View Research
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks - Yahoo Finance
iRhythm at 45th Annual William Blair Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Heart Device Maker iRhythm Gets Investor Claims Trimmed - Law360
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
iRhythm Fails to Snuff Investor Suit Over Heart Monitor Flaws - Bloomberg Law News
Healthcare Tech And Innovation: Heart Monitors Improving - Seeking Alpha
iRhythm Technologies Inc (IRTC) Stock Price Up 3.75% on Jun 3 - GuruFocus
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Smart Wearable ECG Monitors Market Size Report, 2030 - Grand View Research
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC) - ACCESS Newswire
(IRTC) Trading Signals - news.stocktradersdaily.com
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Irhythm Technologies Inc-Aktie (IRTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Patterson Chad | Chief Commercial Officer |
Jun 23 '25 |
Sale |
150.00 |
936 |
140,400 |
48,929 |
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):